An alternative to 'Turing Test'
Georgia Tech researcher develops test to assess a computer's capacity for human-level intelligence through its ability to create rather than to converse or deceive
2014-11-19
(Press-News.org) A Georgia Tech professor is offering an alternative to the celebrated "Turing Test" to determine whether a machine or computer program exhibits human-level intelligence. The Turing Test - originally called the Imitation Game - was proposed by computing pioneer Alan Turing in 1950. In practice, some applications of the test require a machine to engage in dialogue and convince a human judge that it is an actual person.
Creating certain types of art also requires intelligence observed Mark Riedl, an associate professor in the School of Interactive Computing at Georgia Tech, prompting him to consider if that might lead to a better gauge of whether a machine can replicate human thought.
"It's important to note that Turing never meant for his test to be the official benchmark as to whether a machine or computer program can actually think like a human," Riedl said. "And yet it has, and it has proven to be a weak measure because it relies on deception. This proposal suggests that a better measure would be a test that asks an artificial agent to create an artifact requiring a wide range of human-level intelligent capabilities."
To that end, Riedl has created the Lovelace 2.0 Test of Artificial Creativity and Intelligence.
For the test, the artificial agent passes if it develops a creative artifact from a subset of artistic genres deemed to require human-level intelligence and the artifact meets certain creative constraints given by a human evaluator. Further, the human evaluator must determine that the object is a valid representative of the creative subset and that it meets the criteria. The created artifact needs only meet these criteria but does not need to have any aesthetic value. Finally, a human referee must determine that the combination of the subset and criteria is not an impossible standard.
The Lovelace 2.0 Test stems from the original Lovelace Test as proposed by Bringsjord, Bello and Ferrucci in 2001. The original test required that an artificial agent produce a creative item in such a way that the agent's designer cannot explain how it developed the creative item. The item, thus, must be created in such a way that is valuable, novel and surprising.
Riedl contends that the original Lovelace test does not establish clear or measurable parameters. Lovelace 2.0, however, enables the evaluator to work with defined constraints without making value judgments such as whether the artistic object created surprise.
Riedl's paper, available here, will be presented at Beyond the Turing Test, an Association for the Advancement of Artificial Intelligence (AAAI) workshop to be held January 25 - 29, 2015, in Austin, Texas.
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2014-11-19
Empagliflozin (trade name Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether the drug offers an added benefit over the appropriate comparator therapies in these patient groups.
According to the findings, such an added benefit is not proven: For four of five research questions, the manufacturer presented no relevant data in its dossier. For the fifth ...
2014-11-19
Following a 5,000 km long ocean survey, research published in the Proceedings of the National Academy of Sciences presents a new way to measure how the acidification of water is affecting marine ecosystems over an entire oceanic basin.
As a result of man-made emissions, the content of CO2 in the atmosphere and oceans has increased dramatically during recent decades. In the ocean, the accumulating CO2 is gradually acidifying the surface waters, making it harder for shelled organisms like corals (Figure 1) and certain open sea plankton to build their calcium carbonate ...
2014-11-19
Flexible electronic sensors based on paper -- an inexpensive material -- have the potential to some day cut the price of a wide range of medical tools, from helpful robots to diagnostic tests. Scientists have now developed a fast, low-cost way of making these sensors by directly printing conductive ink on paper. They published their advance in the journal ACS Applied Materials & Interfaces.
Anming Hu and colleagues point out that because paper is available worldwide at low cost, it makes an excellent surface for lightweight, foldable electronics that could be made and ...
2014-11-19
Now that car makers have demonstrated through hybrid vehicle success that consumers want less-polluting tailpipes, they are shifting even greener. In 2015, Toyota will roll out the first hydrogen fuel-cell car for personal use that emits only water. An article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, explains how hydrogen could supplant hybrid and electric car technology -- and someday, even spur the demise of the gasoline engine.
Melody M. Bomgardner, a senior editor at C&EN, notes that the first fuel-cell vehicles ...
2014-11-19
Exposure to peanut proteins in household dust may be a trigger of peanut allergy, according to a study published today in the Journal of Allergy and Clinical Immunology.
The study was conducted in 359 children aged 3-15 months taking part in the NIH-sponsored Consortium for Food Allergy Research (CoFAR) study. These children were at high risk of developing a peanut allergy based on having likely milk or egg allergy or eczema. The study found that the risk of having strong positive allergy tests to peanut increased with increasingly higher amounts of peanut found in ...
2014-11-19
UCLA biochemists have created the largest-ever protein that self-assembles into a molecular "cage." The research could lead to synthetic vaccines that protect people from the flu, HIV and other diseases.
At a size hundreds of times smaller than a human cell, it also could lead to new methods of delivering pharmaceuticals inside of cells, or to the creation of new nanoscale materials.
The protein assembly, which is shaped like a cube, was constructed from 24 copies of a protein designed in the laboratory of Todd Yeates, a UCLA professor of chemistry and biochemistry. ...
2014-11-19
A new treatment for Marfan syndrome, a rare genetic disease that can lead to heart problems, works as well as the currently recommended medical therapy, beta blockers, according to an article in the New England Journal of Medicine.
Angela Sharkey, M.D., professor of pediatrics at Saint Louis University, and a study author, said researchers found losartan, which had been more effective in an animal model of Marfan syndrome, was equally effective to a high dose of the beta blocker atenolol.
"While there may be certain patients who respond better to one drug or another, ...
2014-11-19
Researchers from the University of Melbourne found unlike other laser treatments, this new faster laser did not result in damage to the retina, the sensitive light detecting tissue at the back of the eye.
Associate Professor Erica Fletcher from the Department of Anatomy and Neuroscience said this was the first report detailing how this new laser treatment may improve eye health in those with AMD. In the early stages, the disease is characterised by the presence of small fatty deposits called drusen and thickening in a membrane at the back of the eye.
Published this ...
2014-11-19
Barcelona, Spain: A new drug that targets not only common cancer-causing genetic mutations in patients with non-small cell lung cancer (NSCLC), but also a form of the mutation that causes resistance to treatment, has shown promising results in patients in a phase I/II clinical trial. The research will be presented today (Friday) at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain.
Approximately 10-15% of Caucasian and 30-35% of Asian patients with NSCLC have a mutation in the epidermal growth factor receptor (EGFR), which ...
2014-11-19
If it's help a woman needs, maybe she should wear high heels. That's the message from Nicolas Guéguen of the Université de Bretagne-Sud in France, after he observed how helpful men are towards women in high heels versus those wearing flat, sensible shoes. The study, published in Springer's journal Archives of Sexual Behavior, is the first ever to investigate how the height of a woman's shoe heel influences how men behave towards her.
Research across various cultures has shown at length how important physical features, such as body size and the style and color ...
LAST 30 PRESS RELEASES:
[Press-News.org] An alternative to 'Turing Test'
Georgia Tech researcher develops test to assess a computer's capacity for human-level intelligence through its ability to create rather than to converse or deceive
